DW
Publicaties op Oncologisch.com
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patiënt...
Pathologic Response of Fase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemothera...
Perioperatieve versus postoperatieve adjuvante oxaliplatine-S-1 bij maagcarcinoom: RESOLVE fase III